Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2H
Elena Kudryashova, … , Irina Kramerova, Melissa J. Spencer
Elena Kudryashova, … , Irina Kramerova, Melissa J. Spencer
Published April 16, 2012
Citation Information: J Clin Invest. 2012;122(5):1764-1776. https://doi.org/10.1172/JCI59581.
View: Text | PDF
Research Article Muscle biology Article has an altmetric score of 7

Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2H

  • Text
  • PDF
Abstract

Mutations in the E3 ubiquitin ligase tripartite motif-containing 32 (TRIM32) are responsible for the disease limb-girdle muscular dystrophy 2H (LGMD2H). Previously, we generated Trim32 knockout mice (Trim32–/– mice) and showed that they display a myopathic phenotype accompanied by neurogenic features. Here, we used these mice to investigate the muscle-specific defects arising from the absence of TRIM32, which underlie the myopathic phenotype. Using 2 models of induced atrophy, we showed that TRIM32 is dispensable for muscle atrophy. Conversely, TRIM32 was necessary for muscle regrowth after atrophy. Furthermore, TRIM32-deficient primary myoblasts underwent premature senescence and impaired myogenesis due to accumulation of PIAS4, an E3 SUMO ligase and TRIM32 substrate that was previously shown to be associated with senescence. Premature senescence of myoblasts was also observed in vivo in an atrophy/regrowth model. Trim32–/– muscles had substantially fewer activated satellite cells, increased PIAS4 levels, and growth failure compared with wild-type muscles. Moreover, Trim32–/– muscles exhibited features of premature sarcopenia, such as selective type II fast fiber atrophy. These results imply that premature senescence of muscle satellite cells is an underlying pathogenic feature of LGMD2H and reveal what we believe to be a new mechanism of muscular dystrophy associated with reductions in available satellite cells and premature sarcopenia.

Authors

Elena Kudryashova, Irina Kramerova, Melissa J. Spencer

×

Figure 8

Accumulation of PIAS4 and sumoylated proteins in Trim32–/– cells.

Options: View larger image (or click on image) Download as PowerPoint
Accumulation of PIAS4 and sumoylated proteins in Trim32–/– cells.
   
(A...
(A and B) Primary myogenic cells were treated with 50 μM of the inhibitor of proteasome activity, MG132, for 1, 3, or 6 hours. Cells represented by the lane labeled “0” were treated with DMSO (vehicle) alone for 6 hours. MG132 treatment for 6 hours had a toxic effect on the cells, which showed marked signs of cell death (the majority of the cells were rounded and detached). (A) Western blot analysis of the treated cells using anti-PIAS4, anti-ubiquitin, anti–SUMO-1, and anti–SUMO-2/3 antibody. Vinculin is shown as a loading control. Note the reduction of band densities in lanes representing 6 hours in MG132 due to cellular toxicity. (B) Densitometry data normalized to vinculin relative to vehicle-treated Trim32+/+ values and shown as mean ± sem (*P < 0.05). (C) RNAi using an siRNA targeting Pias4 or nontargeting control in myoblast cultures. Western blot analysis demonstrates expression of PIAS4, HP1γ, p53, and SUMO-2/3 in myogenic cells. A Ponceau S–stained blot is shown as a loading control. Numbers under the blots are densitometry data normalized to loading and represent a fold difference of the indicated protein expression in myoblasts relative to the value in the Trim32+/+ culture treated with nontargeting control siRNA. Note that the asterisk denotes unconjugated free SUMO-2/3; only conjugated SUMO species (shown in bracket) were used for densitometry of SUMO-2/3 blots.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 20 patents
99 readers on Mendeley
See more details